Bank of America’s Bioventus BVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$786K Buy
86,057
+24,723
+40% +$207K ﹤0.01% 4639
2025
Q4
$456K Buy
61,334
+28,944
+89% +$208K ﹤0.01% 4958
2025
Q3
$217K Sell
32,390
-8,800
-21% -$61.1K ﹤0.01% 6241
2025
Q2
$273K Sell
41,190
-84,782
-67% -$601K ﹤0.01% 6041
2025
Q1
$1.15M Sell
125,972
-48,582
-28% -$485K ﹤0.01% 5124
2024
Q4
$1.83M Buy
174,554
+6,113
+4% +$72.3K ﹤0.01% 4526
2024
Q3
$2.01M Buy
168,441
+125,498
+292% +$1.09M ﹤0.01% 4558
2024
Q2
$247K Sell
42,943
-5,662
-12% -$31.1K ﹤0.01% 5775
2024
Q1
$253K Sell
48,605
-18,325
-27% -$89.6K ﹤0.01% 5768
2023
Q4
$353K Buy
66,930
+28,615
+75% +$113K ﹤0.01% 5743
2023
Q3
$126K Sell
38,315
-11,037
-22% -$38.7K ﹤0.01% 6143
2023
Q2
$143K Sell
49,352
-13,767
-22% -$26.4K ﹤0.01% 6044
2023
Q1
$67.5K Buy
63,119
+25,796
+69% +$49.3K ﹤0.01% 6398
2022
Q4
$97.4K Sell
37,323
-1,084,140
-97% -$4.73M ﹤0.01% 6246
2022
Q3
$7.85M Sell
1,121,463
-68,697
-6% -$538K ﹤0.01% 2871
2022
Q2
$8.12M Buy
1,190,160
+1,169,541
+5,672% +$11.9M ﹤0.01% 2894
2022
Q1
$290K Sell
20,619
-6,197
-23% -$83K ﹤0.01% 6217
2021
Q4
$389K Buy
26,816
+26,005
+3,207% +$370K ﹤0.01% 6073
2021
Q3
$12K Buy
811
+357
+79% +$5.49K ﹤0.01% 7520
2021
Q2
$8K Sell
454
-12,053
-96% -$194K ﹤0.01% 7343
2021
Q1
$192K Buy
+12,507
New +$178K ﹤0.01% 6071

Other funds holding BVS

Bank of America's BVS Position: Q1 2026 in Review

Bank of America increased its Bioventus (BVS) stake by 40% in Q1 2026, buying an estimated $207K and bringing the position to 86,057 shares worth $786K. The position accounts for ﹤0.01% of the portfolio, ranked #4639.

Bank of America first reported a position in BVS in Q1 2021 and has held it in 21 quarters since. The position peaked at $8.12M in Q2 2022. 157 funds tracked by Wall St. Rank hold BVS as of Q1 2026.

  • Bank of America held 86,057 shares of Bioventus worth $786K as of Q1 2026.
  • Bank of America bought 24,723 Bioventus shares in Q1 2026, an estimated $207K.
  • Bioventus made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #4639 holding.
  • Bank of America first reported a position in Bioventus in Q1 2021 and has held it in 21 quarters since.
  • Bank of America's Bioventus position peaked at $8.12M in Q2 2022.
  • 157 funds tracked by Wall St. Rank held Bioventus as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.